Home › Myelofibrosis › Colorado › Denver
Myelofibrosis clinical trials in Denver, CO
5 studies for Myelofibrosis are looking for participants at sites in and around Denver (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
RecruitingPhase 3
- Rocky Mountain Cancer Centers, Denver
A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms
RecruitingPhase 1
- Colorado Blood Cancer Institute, Denver
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
RecruitingPhase 1/2
- Blood Cancer Center, Denver
A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
RecruitingPhase 1
- Colorado Blood Cancer Institute, Denver
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Denver
Myelofibrosis trials in other cities
- New York City, NY21 studies
- Houston, TX20 studies
- Boston, MA13 studies
- Durham, NC13 studies
- Columbus, OH12 studies
- Seattle, WA12 studies
- Tampa, FL11 studies
- Nashville, TN11 studies
- Miami, FL11 studies
- Salt Lake City, UT11 studies
- Ann Arbor, MI10 studies
- Atlanta, GA10 studies
Other studies in Denver
- Breast Cancer26 studies
- Multiple Myeloma26 studies
- Non-Small Cell Lung Cancer25 studies
- Metastatic Cancer25 studies
- Colorectal Cancer22 studies
- Melanoma19 studies
- Prostate Cancer19 studies
- Ovarian Cancer17 studies
- Endometrial Cancer15 studies
- Cancer (all types)15 studies
- Lung Cancer15 studies
- Non-Hodgkin Lymphoma14 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.